The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation ...

The antibody, called 04_A06, blocked 98.5% of more than 300 different HIV strains in lab tests, including many resistant to ...

It’s been a busy week in the life sciences! Discover the latest developments below in this edition of Week in […] ...

New research reveals how HIV cleverly hides in different tissues by integrating into a host cell's DNA, explaining its persistence despite antiretroviral therapy.

According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...

The event is part of a multinational effort to expand access to one of the most exclusive, elite sports. In recent years, ...

Three large drug companies shared new study results this week that point to more progress in breast cancer treatment. The ...

The other gene is GRM3, which helps the brain process information and stay flexible. This gene has been linked to mental ...

On June 28, 2012, the most significant scientific breakthrough of the first quarter of the 21st century was announced to the ...

India faces a silent anaemia epidemic, with rising cases across all demographics. In most cases, public tend to disregard its ...